Crossmark Global Holdings’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,570
Closed -$631K 1285
2022
Q3
$631K Sell
2,570
-150
-6% -$40.5K 0.02% 683
2022
Q2
$673K Hold
2,720
0.02% 691
2022
Q1
$901K Buy
2,720
+50
+2% +$15.4K 0.02% 665
2021
Q4
$959K Sell
2,670
-4,680
-64% -$1.58M 0.02% 641
2021
Q3
$2.39M Sell
7,350
-550
-7% -$186K 0.06% 340
2021
Q2
$2.47M Sell
7,900
-520
-6% -$160K 0.06% 324
2021
Q1
$2.68M Sell
8,420
-1,140
-12% -$365K 0.07% 298
2020
Q4
$3.1M Buy
9,560
+6,670
+231% +$1.84M 0.08% 280
2020
Q3
$801K Sell
2,890
-130
-4% -$37.5K 0.02% 606
2020
Q2
$730K Sell
3,020
-20
-0.7% -$4.02K 0.02% 633
2020
Q1
$441K Sell
3,040
-104
-3% -$17.3K 0.02% 695
2019
Q4
$536K Sell
3,144
-147
-4% -$27.3K 0.01% 768
2019
Q3
$585K Buy
3,291
+49
+2% +$10.6K 0.02% 725
2019
Q2
$845K Buy
3,242
+104
+3% +$27.6K 0.02% 596
2019
Q1
$896K Sell
3,138
-109
-3% -$36.2K 0.03% 580
2018
Q4
$1.05M Sell
3,247
-3,795
-54% -$1.32M 0.03% 517
2018
Q3
$3.17M Buy
7,042
+92
+1% +$36.3K 0.08% 282
2018
Q2
$2.84M Buy
6,950
+733
+12% +$266K 0.08% 290
2018
Q1
$1.81M Sell
6,217
-310
-5% -$78.6K 0.05% 440
2017
Q4
$1.22M Sell
6,527
-563
-8% -$105K 0.03% 575
2017
Q3
$1.2M Buy
+7,090
New +$1.07M 0.03% 558
2016
Q3
$1.2M Buy
+7,090
New +$849K 0.03% 558

Other funds holding ABMD

Crossmark Global Holdings's ABMD Position: Q4 2022 in Review

Crossmark Global Holdings sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 2,570 shares — an estimated $631K sold.

Crossmark Global Holdings first reported a position in ABMD in Q3 2016 and held it in 22 quarters. The position peaked at $3.17M in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Crossmark Global Holdings reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Crossmark Global Holdings sold 2,570 Abiomed Inc shares in Q4 2022, an estimated $631K.
  • Crossmark Global Holdings first reported a position in Abiomed Inc in Q3 2016 and held it in 22 quarters.
  • Crossmark Global Holdings's Abiomed Inc position peaked at $3.17M in Q3 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Crossmark Global Holdings's 13F filing for Q4 2022, filed 19 Jan 2023.